Reports on Insulin Resistance Findings from Tongji University School of Medicine Provide New Insights (Insulin resistance impairs biologic agent response in moderate-to-severe plaque psoriasis: insights from a prospective cohort study in China).

A recent study conducted in China has found that insulin resistance (IR) can impair the effectiveness of biologic agents in treating moderate-to-severe plaque psoriasis. The study, based on a prospective cohort design, analyzed data from 290 patients and found that those with high IR had lower response rates to treatment compared to those with low IR. The findings suggest that IR is associated with reduced effectiveness of biologics in psoriasis patients. Further research is needed to better understand the relationship between IR and psoriasis treatment. [Extracted from the article]

Copyright of Diabetes Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)